Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Rubella IgG Assay Launched

By HospiMedica staff writers
Posted on 26 Mar 2007
An assay has been launched that aids in the determination of immunity to rubella infection, commonly known as German measles.

The Vitros Rubella IgG assay1 determines if IgG antibodies to the rubella virus are in the blood. More...
The presence of IgG antibodies may indicate a recent or past rubella infection or that a rubella vaccine has been given and is providing adequate protection. The Vitros ECi/ECiQ immunodiagnostic system is a simple-to-use, flexible, and fully-automated
laboratory testing system that provides true continuous STAT, random access capabilities for routine and specialty immunodiagnostic testing. The system uses proprietary enhanced chemiluminescence detection.

Rubella is a viral infection that manifests itself as a mild rash on the skin and a low-grade fever. It is primarily transmitted via droplets from the nose or throat that others inhale. It is also transmitted from a pregnant woman's bloodstream to the unborn child. It is generally a mild disease in children and healthy adults. However, there can be significant medical danger if a pregnant woman has an active infection and the developing unborn child becomes infected. This can lead to death of the unborn child or birth defects such as blindness, deafness, metal retardation, and cardiac abnormalities. The risk of fetal infection and the severity of defects are greatest during the first trimester.

Ortho-Clinical Diagnostics (Raritan, NJ, USA), a Johnson & Johnson company, announced U.S. Food and Drug Administration (FDA) clearance and availability of the Vitros rubella IgG assay1. The Vitros ECi/ECiQ immunodiagnostic system uses Intellicheck technology, a technology designed to verify diagnostic checks throughout automated sample and assay processing. Intellicheck serves to increase the integrity and security of reported patient results while helping to ensure greater confidence and productivity for laboratories that generate these results.

"Even though the incidence of rubella infections [is at a] record low, routine rubella IgG testing is a vital part of pre-natal screening to determine the immune status of females planning pregnancy” said Michael Waller, M.D., vice president, clinical and medical affairs for Ortho-Clinical Diagnostics. "Once the results are known, appropriate vaccination or precautions can be made.”


Related Links:
Ortho-Clinical Diagnostics

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Infant Resuscitator
Easypuff
External Defibrillator
HeartSave Y | YA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.